Discover the world of Recursive Self-Improvement (RSI) in AI. From I.J. Good's intelligence explosion to modern self-healing code and clinical applications, explore who is developing it, how it works, ...

Founded by former Google DeepMind scientists, Poetiq emerges from "stealth" after setting a new state-of-the-art (SOTA) on ...

For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

When Apple released iOS 26 back in September, many iPhone users were eager to try its new customizations, features, and security updates. But, as with major software transitions, the launch hasn't ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

America’s cost-of-living problem is simple math: Inflation spiked several years ago and paychecks haven’t had enough time to catch up. The latest jobs report revealed Tuesday that the problem got even ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. Before market open, ...

If you like the idea of a ‘whodunnit’ style detective game, but one without any murder or grizzly crime, you’ll probably love Little Problems. It’s a cosy detective game, where instead of solving ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Is anti-Semitism in American political discourse actually just a carefully cultivated deception? Over the weekend, Elon Musk’s X revealed the location of every account on the site, and the results ...